Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

32.66
Delayed Data
As of Dec 09
 -1.83 / -5.31%
Today’s Change
8.00
Today|||52-Week Range
63.73
-15.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues37.3M14.2M9.8M1.3M
 
 
 
 
 
Depreciation And Amortization1.5M1.3M3.7M5.2M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses65.3M101.9M139.7M207.0M
 
 
 
 
 
Research And Development52.3M71.7M94.1M146.4M
 
 
 
 
 
Total Operating Expenses66.8M103.2M143.4M212.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.5M-89.0M-133.7M-211.0M
 
 
 
 
 
Extraordinary Charge-92.1M-23.3M-2.8M-9.2M
 
 
 
 
 
Other Expenses135.0K200.0K679.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-121.3M-112.0M-135.8M-220.0M
 
 
 
 
 
Net Income-121.3M-112.0M-135.8M-220.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.6M33.9M40.0M42.3M
 
 
 
 
 
Shares To Calculate EPS Diluted23.6M33.9M40.0M42.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.14-$3.31-$3.39-$5.20
 
 
 
 
 
EPS Diluted-$5.14-$3.31-$3.39-$5.20